Home > Healthcare > Medical Devices > Therapeutic Devices > Lung Stent Market
Lung Stent Market size was valued at over USD 165 million in 2022 and is poised to record over 11.5% CAGR from 2023 to 2032, owing to the high prevalence of COPD (chronic obstructive pulmonary disease) and post-tuberculosis stenosis globally.
COPD, a prominent cause of morbidity and death, frequently results in significant airway blockage. For instance, a 2022 report from CDC estimates that more than 150,000 Americans die from COPD every year. It has also been reported that over 90% of COPD fatalities occurred in middle- and low-income countries, and there is currently no cure for the condition. Lung stents offer less invasive remedies by preserving airway patency and enhancing airflow, which reduces symptoms and enhances the quality of life for patients. As a result, the growing patient base will drive up the product demand, further contributing to the market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Lung Stent Market Size in 2022: | USD 165.9 million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 11.7% |
2032 Value Projection: | USD 523.0 million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 250 |
Tables, Charts & Figures: | 821 |
Segments covered: | Product, Device Type, Material, Patient, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
However, the industry expansion may be hampered to some extent by the influx of stringent compliances and series of time-consuming tests that are required to get authorization for selling the lung stents. Additionally, gadgets categorized as Class II devices pose minimal risk to the general public's health and moderate risks to the individual users. Therefore, during the analysis timeframe, these factors may have an impact on the market progression.